Daiwa Securities Group Inc. Assembly Biosciences, Inc. Put Options Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ASMB
# of Institutions
1Shares Held
16.3KCall Options Held
0Put Options Held
0About ASSEMBLY BIOSCIENCES, INC.
- Ticker ASMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,436,900
- Market Cap $753M
- Description
- Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...